ARCHIVES

Oral UFT Equivalent To FULV In Stage II and III Colon Cancer

This article is from The Cancer Letter archive.

Vol. 27 No. 7 | July 30, 2004

Download PDF Visit The Full Archive

Related Articles

FDA Discloses Responses, Toxicities For Burzynski’s “Antineoplastons”

April 24, 1998

NCI Cooperative Group Clinical Trials Approved

October 29, 2010

NCI Programs: Seven Win Awards For Cancer Genetics Network, Informatics

July 31, 1998

In Brief: McDonnell Foundation Selects Five For Awards; James Benson Is Named Interim FDA Head

November 24, 1989

Vanderbilt Wins Lung Cancer SPORE Grant.

May 18, 2001

Hammer Says He’ll Ask Reagan For Bigger NCI Budget

October 30, 1981